The Danish Medicines Council was established on January 1, 2017. The Council and AMGROS assesses the value of new hospital drugs based on a clinical assessment and categorization of the clinical value using the Grades of Recommendation Assessment, Development and Evaluation system, an economic assessment of the added costs per patient as well as the overall budgetary impact to set a framework for the procurement of the same. The aim of this study was to describe the new process and the outcomes of the recommendations during first year of implementation.
Authors: Dibbern T, Medin E
To find out more about this poster you can register to download it here after the ISPOR event.